中国妇幼健康研究
中國婦幼健康研究
중국부유건강연구
Chinese Journal of Woman and Child Health Research
2015年
5期
979-980,996
,共3页
新三联%超声晶氧%胎儿窘迫%疗效分析
新三聯%超聲晶氧%胎兒窘迫%療效分析
신삼련%초성정양%태인군박%료효분석
new triple treatment%ultrasound crystal oxygen%fetal distress%efficacy analysis
目的：探讨新三联联合超声晶氧治疗胎儿窘迫的疗效，为临床诊断治疗提供参考。方法将174例足月分娩活跃期出现胎儿窘迫的孕妇按照随机数字表法将其分为对照组和治疗组，每组各87例；对照组给予超声晶氧治疗，治疗组在对照组治疗基础上给予新三联治疗；比较两组胎心、羊水粪染改善情况， Apgar评分情况，胎儿出生脐动脉血气分析情况。结果治疗组30min内胎心恢复率（93．10％）显著高于对照组（72．41％），且有显著性差异（χ2＝4．863，P＜0．05）；治疗组胎儿娩出时羊水无粪染率显著高于对照组，且有显著性差异（χ2＝16．082，P＜0．05）；治疗组1min Apgar评分正常者显著高于对照组，且有显著性差异（χ2＝13．931，P＜0．05）；治疗组胎儿出生脐动脉血气酸碱度（PH）、氧分压（PO2）、碱剩余（BE）均高于对照组，二氧化碳分压（PCO2）指标低于对照组，差异有统计学意义（t值分别为19．571、8．272、12．989、19．314，均P＜0．001）。结论新三联联合超声晶氧治疗胎儿窘迫疗效确切，能显著改善胎儿娩出时羊水粪染情况、1 min Apgar评分及出生脐动脉血气，具有重要的研究价值，值得在临床上推广使用。
目的：探討新三聯聯閤超聲晶氧治療胎兒窘迫的療效，為臨床診斷治療提供參攷。方法將174例足月分娩活躍期齣現胎兒窘迫的孕婦按照隨機數字錶法將其分為對照組和治療組，每組各87例；對照組給予超聲晶氧治療，治療組在對照組治療基礎上給予新三聯治療；比較兩組胎心、羊水糞染改善情況， Apgar評分情況，胎兒齣生臍動脈血氣分析情況。結果治療組30min內胎心恢複率（93．10％）顯著高于對照組（72．41％），且有顯著性差異（χ2＝4．863，P＜0．05）；治療組胎兒娩齣時羊水無糞染率顯著高于對照組，且有顯著性差異（χ2＝16．082，P＜0．05）；治療組1min Apgar評分正常者顯著高于對照組，且有顯著性差異（χ2＝13．931，P＜0．05）；治療組胎兒齣生臍動脈血氣痠堿度（PH）、氧分壓（PO2）、堿剩餘（BE）均高于對照組，二氧化碳分壓（PCO2）指標低于對照組，差異有統計學意義（t值分彆為19．571、8．272、12．989、19．314，均P＜0．001）。結論新三聯聯閤超聲晶氧治療胎兒窘迫療效確切，能顯著改善胎兒娩齣時羊水糞染情況、1 min Apgar評分及齣生臍動脈血氣，具有重要的研究價值，值得在臨床上推廣使用。
목적：탐토신삼련연합초성정양치료태인군박적료효，위림상진단치료제공삼고。방법장174례족월분면활약기출현태인군박적잉부안조수궤수자표법장기분위대조조화치료조，매조각87례；대조조급여초성정양치료，치료조재대조조치료기출상급여신삼련치료；비교량조태심、양수분염개선정황， Apgar평분정황，태인출생제동맥혈기분석정황。결과치료조30min내태심회복솔（93．10％）현저고우대조조（72．41％），차유현저성차이（χ2＝4．863，P＜0．05）；치료조태인면출시양수무분염솔현저고우대조조，차유현저성차이（χ2＝16．082，P＜0．05）；치료조1min Apgar평분정상자현저고우대조조，차유현저성차이（χ2＝13．931，P＜0．05）；치료조태인출생제동맥혈기산감도（PH）、양분압（PO2）、감잉여（BE）균고우대조조，이양화탄분압（PCO2）지표저우대조조，차이유통계학의의（t치분별위19．571、8．272、12．989、19．314，균P＜0．001）。결론신삼련연합초성정양치료태인군박료효학절，능현저개선태인면출시양수분염정황、1 min Apgar평분급출생제동맥혈기，구유중요적연구개치，치득재림상상추엄사용。
Objective To explore the clinical efficacy of new triple treatment combined with ultrasound crystal oxygen therapy on fetal distress, so as to provide reference for clinical diagnosis and treatment.Methods A total of 174 cases of full-term delivery with fetal distress at active stage were divided into control group and treatment group according to random number table with 87 cases in each group. The control group received ultrasound crystal oxygen therapy, while the treatment group was given new triple therapy additionally.Fetal heart rate, improvement of meconium-stained amniotic fluid, Apgar score and umbilical arterial blood gas analysis at birth were compared between two groups.Results The heart recovery rate within 30min in the treatment group (93.10%) was significantly higher than that in the control group (72.41%) (χ2 =4.863,P<0.05).The rate of amniotic fluid without meconium in the treatment group was significantly higher (χ2 =16.082, P <0.05).There were more cases with normal Apgar scores in the treatment group, and the difference was significant (χ2 =13.931, P<0.05).Compared with the control group, cases in the treatment group had higher birth umbilical arterial blood gas PH, PO2 and BE but lower PCO2 index, and there were significant differences ( t value was 19.571, 8.272, 12.989 and 19.314, respectively, all P<0.001).Conclusion The new triple treatment combined with ultrasonic crystal oxygen treatment can obtain definite efficacy, improve meconium at birth and 1min Apgar score as well as umbilical arterial blood gas.It is of great importance and worthy of promotion in clinics.
